ISPC vs NI · rev $9.3M vs P/E 23, rev $5.28B
iSpecimen Inc (ISPC) versus NiSource Inc (NI) — a side-by-side from cached financials, not a winner call.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
NiSource Inc (NI) is a utilities - regulated gas company listed on NYSE.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
Latest reported NI revenue for 2024-12-31 was $5.28B. Net income was $844.7M. Revenue was down 1.2% from 2023-12-31 to 2024-12-31. NI currently screens at market cap $22.42B and trailing P/E 23.3.
ISPC currently screens at market cap $4.4M. NI currently screens at market cap $22.42B and trailing P/E 23.3.
Not investment advice. Open the ISPC and NI stock pages for the full models.
Not investment advice.